Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P A Routledge

Showing results (151-160 of 165) with videos related to

Pageof 17
Sort By:
Circulation|February 1, 1982
Pirmenol, a new antiarrhythmic agent: initial study of efficacy, safety and pharmacokineticsS C Hammill, D G Shand, P A Routledge, et al.
British Journal of Clinical Pharmacology|July 1, 1989
The effect of theophylline on thyrotoxic tremorD C Buss, D I Phillips, M D Littley, et al.
British Journal of Clinical Pharmacology|December 5, 2015
A comparative study of methyldopa and labetalol in the treatment of hypertensionG L Sanders, D M Davies, G M Gales, et al.
European Journal of Clinical Pharmacology|December 18, 1978
Labetalol, a cross-over double blind controlled trialG L Sanders, P A Routledge, J G Rao, et al.
European Journal of Clinical Pharmacology|January 1, 1991
Plasma adenosine concentrations during adenosine-induced respiratory stimulation in manP G Reid, A H Watt, W J Penny, et al.
European Journal of Clinical Pharmacology|March 11, 1977
Dose-titrated, double-blind, cross-over comparison of a selective beta-blocker and methyldopa in the treatment of hypertensionP A Routledge, L V Zrinzo, J G Rao, et al.
British Journal of Clinical Pharmacology|January 1, 1979
A comparative study of methyldopa and labetalol in the treatment of hypertensionG L Sanders, D M Davies, G M Gales, et al.
Clinical and Laboratory Haematology|January 1, 1987
A comparison of 3 and 6 weeks' anticoagulation in the treatment of venous thromboembolismA G Fennerty, J Dolben, P Thomas, et al.
British Journal of Clinical Pharmacology|December 5, 2015
A multicentre open trial of labetalol in New ZealandG L Sanders, D M Davies, G M Gales, et al.
BMJ (Clinical Research Ed.)|February 10, 2007
Anticoagulation for three versus six months in patients with deep vein thrombosis or pulmonary embolism, or both: randomised trialI A Campbell, D P Bentley, R J Prescott, et al.
Pageof 17

Showing results (151-160 of 165) with videos related to

Sort By:
Pageof 17
Circulation|February 1, 1982
Pirmenol, a new antiarrhythmic agent: initial study of efficacy, safety and pharmacokineticsS C Hammill, D G Shand, P A Routledge, et al.
British Journal of Clinical Pharmacology|July 1, 1989
The effect of theophylline on thyrotoxic tremorD C Buss, D I Phillips, M D Littley, et al.
British Journal of Clinical Pharmacology|December 5, 2015
A comparative study of methyldopa and labetalol in the treatment of hypertensionG L Sanders, D M Davies, G M Gales, et al.
European Journal of Clinical Pharmacology|December 18, 1978
Labetalol, a cross-over double blind controlled trialG L Sanders, P A Routledge, J G Rao, et al.
European Journal of Clinical Pharmacology|January 1, 1991
Plasma adenosine concentrations during adenosine-induced respiratory stimulation in manP G Reid, A H Watt, W J Penny, et al.
European Journal of Clinical Pharmacology|March 11, 1977
Dose-titrated, double-blind, cross-over comparison of a selective beta-blocker and methyldopa in the treatment of hypertensionP A Routledge, L V Zrinzo, J G Rao, et al.
British Journal of Clinical Pharmacology|January 1, 1979
A comparative study of methyldopa and labetalol in the treatment of hypertensionG L Sanders, D M Davies, G M Gales, et al.
Clinical and Laboratory Haematology|January 1, 1987
A comparison of 3 and 6 weeks' anticoagulation in the treatment of venous thromboembolismA G Fennerty, J Dolben, P Thomas, et al.
British Journal of Clinical Pharmacology|December 5, 2015
A multicentre open trial of labetalol in New ZealandG L Sanders, D M Davies, G M Gales, et al.
BMJ (Clinical Research Ed.)|February 10, 2007
Anticoagulation for three versus six months in patients with deep vein thrombosis or pulmonary embolism, or both: randomised trialI A Campbell, D P Bentley, R J Prescott, et al.
Pageof 17